Company news
Fujian Haixi Pharmaceuticals Co., Ltd. news
Latest news releases, newest first.
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
November 2, 2026
Voluntary announcement - progress update on purchases of h shares pursuant to the share incentive scheme
October 20, 2026
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
October 6, 2026
Interim report 2026
September 24, 2026
Voluntary announcement - HX9428 latest data from Phase I and Phase II clinical studies for the treatment of neovascular age-related macular degeneration (nAMD)
September 16, 2026
Fujian Haixi Pharmaceuticals Says US FDA Approves IND Application Of HX9428
August 4, 2026
Fujian Haixi Pharmaceuticals Nominates Chen Tingze As Candidate For Executive Director
July 15, 2026